Compare SNDL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNDL | RXST |
|---|---|---|
| Founded | 2006 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 386.3M | 307.6M |
| IPO Year | 2019 | 2021 |
| Metric | SNDL | RXST |
|---|---|---|
| Price | $1.54 | $7.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 11 |
| Target Price | $5.00 | ★ $11.50 |
| AVG Volume (30 Days) | ★ 897.6K | 710.0K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $134,479,000.00 |
| Revenue This Year | $5.48 | N/A |
| Revenue Next Year | $3.41 | $8.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $6.62 |
| 52 Week High | $2.89 | $27.13 |
| Indicator | SNDL | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 37.11 |
| Support Level | $1.44 | $7.34 |
| Resistance Level | $1.60 | $9.11 |
| Average True Range (ATR) | 0.06 | 0.50 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 46.23 | 20.41 |
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.